RBM12 and cancer: Three variants in RBM12, one variant in NDUFB6, ten variants in DLGAP4-AS1, five variants in ATPV1A, eleven variants in RECK, four variants in SLC35E1, eight variants in RFX3, and eight variants in ATP8A1 were known somatically acquired mutations in various cancers.